MCO vs CME

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

MCO

39.6
AI Score
VS
CME Wins

CME

43.7
AI Score

Investment Advisor Scores

MCO

40score
Recommendation
AVOID NEW MONEY

CME

44score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric MCO CME Winner
Forward P/E 26.8817 23.5294 CME
PEG Ratio 1.8541 4.1991 MCO
Revenue Growth 0.8% 13.0% CME
Earnings Growth 17.8% 16.1% MCO
Tradestie Score 39.6/100 43.7/100 CME
Profit Margin 35.3% 63.5% CME
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD CME

Relative Price Performance (Last 90 Days)

MCO 1M: +10.9% · 3M: +5.4% CME 1M: +13.6% · 3M: +18.2%

Current Technical Phase

MCO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 62

RSI (14): 62.1 · Price: $514.93

CME

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.3% over 20 days), RSI 71

RSI (14): 70.6 · Price: $315.87

Fundamentals Snapshot

Metric MCO CME
Market Cap — —
Forward P/E 27.7 23.9
Trailing P/E 31.2 25.0
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.7% 1.0%
Operating Margin 0.5% 0.7%
EPS 16.39 12.38
Dividend Yield 0.01% 0.02%

Frequently Asked Questions

Based on our detailed analysis, CME is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.